Mi2-β, a critical ATP-dependent helicase component of the nucleosome remodeling and deacetylase (NuRD) complex, is pivotal in regulating chromatin structure and thereby modulating gene expression. This enzyme contributes to the dynamic remodeling of nucleosomes, allowing for the precise control of transcriptional activities necessary for various cellular processes such as differentiation, proliferation, and DNA repair. The NuRD complex, of which Mi2-β is an essential part, integrates chromatin remodeling with histone deacetylation to maintain the epigenetic integrity and transcriptional repression of specific gene sets. Through its action, Mi2-β directly influences the accessibility of transcription factors to DNA, playing a crucial role in the epigenetic regulation of gene expression and in the maintenance of cell-type specific programming. The balanced activity of Mi2-β within the NuRD complex is therefore fundamental to the proper execution of cellular functions and the maintenance of genomic stability.
The inhibition of Mi2-β's function can disrupt the delicate balance of chromatin remodeling and transcriptional regulation, leading to aberrant gene expression patterns associated with various pathologies. Inhibition can occur through multiple mechanisms, including the competitive binding of molecules that directly interfere with the ATPase activity of Mi2-β, thereby hindering its helicase function and the subsequent remodeling of nucleosomes. Additionally, alterations in the expression levels or post-translational modifications of Mi2-β or other NuRD complex components can impact the complex's assembly, localization, and chromatin-binding affinity, indirectly inhibiting Mi2-β's activity. Furthermore, the interaction with inhibitory proteins or non-coding RNAs that sequester Mi2-β away from its target sites on chromatin can also result in the functional inhibition of the NuRD complex. Such mechanisms of inhibition underscore the complexity of regulating Mi2-β activity and the significance of its role in maintaining cellular homeostasis.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Topoisomerase I inhibitor that indirectly modulates Mi2-β by inducing DNA damage and influencing chromatin structure, affecting Mi2-β binding and activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor impacting Mi2-β indirectly by altering histone acetylation, affecting chromatin structure and gene expression. | ||||||